GoPath Diagnostics

04/30/2026

From risk assessment to treatment decisions, we're bringing it all to AUA 2026. 🔬

Join us in Washington, D.C., May 15–18 at Booth 3515, where our team will be walking through ProstateNow and the Triplet Approach—an end-to-end cancer management strategy built around germline testing, comprehensive genomic profiling, and MRD testing.

The conversation starts at Booth 3515. 🏛️

04/28/2026

We'll be at the 31st Annual Executive War College—one of our favorite gatherings of lab and pathology leaders who are serious about moving their operations forward.

If you're working through margin pressure, send-out costs, turnaround times, digital pathology adoption, or scaling without adding headcount, we'd love to connect.

04/24/2026

🏛️ We're heading to the nation's capital! Join us at the AUA Annual Conference in Washington, D.C., May 15–17!

Find us at Booth 3515, where we'll be showcasing ProstateNow®, our germline prostate cancer panel, along with our Triplet Approach to Managing Cancer—integrating hereditary testing, comprehensive genomic profiling, and MRD to support truly personalized care.

04/21/2026

Tomorrow at AACR 2026, we're excited to present new data on CDH17 expression in gastric cancer, a target generating significant momentum in the era of antibody-drug conjugates and precision oncology.

Our study of 73 gastric cancer cases reveals that CDH17 positivity was detected in approximately 15% of patients, helping define a distinct molecular subset that may be well-suited for emerging CDH17-directed therapies. (Abstract #7726)

📋 Section 41, Board 17
📅 Wednesday, April 22 | 9:00 AM – 12:00 PM (PT)
📍 AACR Annual Meeting 2026

This work reflects a proud collaboration with Celnovte Biotechnology and Fetchflow Inc. We look forward to discussing these findings with the oncology and pathology community tomorrow.

04/20/2026

It's Lab Week, and we're kicking it off right! 🎉 Behind every diagnosis, every treatment decision, and every moment of clarity for a patient, a lab professional is making it happen. This week, we're shining the spotlight where it belongs. Cheers to the ones who work tirelessly behind the scenes! 🧬🔬

04/15/2026

From the Capitol to the clinic, innovation starts here. 🏛️

Join us at AUA 2026 in Washington, D.C.
📅 May 15–17 | 📍 Booth 3515

We’ll be showcasing ProstateNow®, our germline prostate cancer panel, along with our Triplet Approach to Managing Cancer—integrating hereditary testing, comprehensive genomic profiling, and MRD to support truly personalized care.

Stop by to see how a more complete testing strategy can drive more confident clinical decisions.

04/10/2026

April is Cancer Prevention and Early Detection Month, a dedicated time to raise awareness about routine screenings and healthy behaviors that can reduce cancer risk. The Prevent Cancer Foundation has put together a range of resources this month, including a personalized screening plan tool, a downloadable awareness toolkit, and more! Early detection leads to better outcomes, more treatment options, and more time with the people you love.

Read more:

April is Cancer Prevention and Early Detection Month, reminding us all of the importance of routine cancer screenings. These screenings can mean better outcomes for your health—that means more treatment options, more healthy days ahead, and more time with the people you love.

04/03/2026

USCAP 2026 brought together some of the sharpest minds in pathology, and we were glad to be part of it at the GoPath booth.

04/02/2026

For the first time in over 15 years, prostate cancer is projected to surpass breast cancer in new US diagnoses in 2026, with 333,830 expected cases. This is a significant milestone that raises big questions about funding, awareness, and screening across all communities. Experts are pointing to rising metastatic cases and more men seeking testing as possible reasons behind the surge.

Read more from The Active Surveillor:

AnCan digs out what everyone, including ACS, missed

03/31/2026

Colorectal cancer rates in the US are moving in two directions, rising in adults under 50 and declining in those 65 and older, according to the American Cancer Society 2026 Colorectal Cancer Statistics report. Early screening and awareness are key factors in catching colorectal cancer before it progresses to a more serious stage. Their latest research page covers recently published studies on exercise, diet, and screening trends worth knowing about.

Read more:

March is Colorectal Cancer Awareness Month. See how American Cancer Society researchers are helping put an end to this disease.

03/24/2026

Another day, another opportunity to connect. 🔬

We're back at booth 456 for Day 2 of USCAP 2026. Swing by, say hello, and let's talk!

03/23/2026

Day 1 of USCAP 2026 is well underway, and the GoPath booth is buzzing! 🎬

Take a peek at what we've been up to so far, and if you're here in San Antonio, there's still plenty of time to come say hello!

📍 Find us at Booth 456!